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Methods A deep brain stimulator was placed in the NAcc of male Wistar-Kyoto rats. Groups were divided into sham(no stimulation), intermittent(3 hrs/day for two weeks) or chronic(constant stimulation for two weeks). Exploratory and anxiety-like behaviors were evaluated using the open field test before and after stimulation. Tissue samples of the prefrontal cortex(PFC) were processed using Western blot analysis of markers of noradrenergic activity that included the noradrenergic synthesizing enzyme tyrosine hydroxylase(TH). Analysis of tissue levels for catecholamines was achieved using high performance liquid chromatography. Finally, morphological properties of cortical pyramidal neurons were assessed using Golgi-cox staining.
Results: Subjects undergoing intermittent and chronic stimulation of the NAcc exhibited an increase in exploratory behavior and reduced anxiety-like behaviors.TH expression levels were decreased in the PFC following intermittent and continuous DBS, and dopamine and norepinephrine levels were decreased following chronic stimulation. Golgi-Cox staining indicated that DBS increased the length of apical and basilar dendrites in pyramidal neurons of the PFC.
Conclusion:
DBS induces behavioral improvement as well as neurochemical and morphological alterations in the PFC that demonstrate changes within the circuitry of the brain different from the target area of stimulation. This observed dendritic plasticity may underlie the therapeutic efficacy of this treatment.
INTRODUCTION

Deep brain stimulation (DBS) is a neurosurgical method that involves a lead or electrode
being placed in a selected region of the brain 1 . It is a reversible procedure that allows an adjustable treatment tailored to the patient. It has become a safe and effective treatment in various neurological disorders including Parkinson's disease and essential tremor 2 3; 4 . More recently, this approach has been applied for the treatment of obsessive-compulsive disorder, epilepsy, and depression 4 .
Depression is a major cause of disability worldwide 9 and accounts for more than $83 billion in domestic costs in the US alone 10 . Lifetime prevalence varies widely, from 3% in Japan to 17% in the US; however, in most countries, the number of people who suffer from depression at one time in their lives falls within an 8-12% range 11; 12 . Most patients are treated with antidepressant medications and some with psychotherapy or counseling. A minority is treated with electroconvulsive therapy 13 .
The role of the prefrontal cortex is important in understanding the nucleus accumbens and its circuitry. It has been shown that the nucleus accumbens core is involved in addiction and drug behavior and the nucleus accumbens shell (NAccS) is involved in pleasure, fear behavior, and food intake. 27; 28; 29 The nucleus accumbens has intricate connections with the prefrontal cortex and limbic system. It is these connections that are thought to be involved in the underlying symptomatology seen in depression. Therefore, DBS to the nucleus accumbens is a potential target in the treatment of depression and its effects on the prefrontal cortex become of interest.
Animal models of epilepsy have benefited from stimulation of the subthalamic nucleus, substantia nigra and anterior thalamus 5; 6; 7 . Rats maintained on a high fat diet, as a model of obesity, experienced significant and sustained weight loss following continuous stimulation of . Neuroplasticity, also known as brain plasticity can be defined as changes that occur in organization of the brain as a result of experience 24 . Areas related to memory formation, such as the hippocampus and dentate gyrus are highly plastic and produce new neurons in a continuous fashion into adulthood 24 . It has been shown that changes in long-term potentiation of cells induced by high-frequency stimulation of the subthalamic nucleus is a mechanism that determines the effectiveness of DBS in the treatment of Parkinson's disease 25 . Thus, this study aimed to show a relationship between DBS-induced changes in behavior with potential neurochemical and morphological changes.
Owing to the importance of the NAcc in regulating motivated behaviors and mood control 26; 27; 28; 29 , the hypothesis that DBS of this region may be relevant in the treatment of depression was tested in the present study. Behavioral studies were conducted following stimulation of the NAcc and subsequently neurochemical and morphological changes were assessed in the prefrontal cortex (PFC).
MATERIALS AND METHODS
Animals
The animal procedures used were approved by the Institutional Animal Care and Use were allowed to acclimate to the animal housing facility for several days prior to the onset of the study. All efforts were made to utilize only the minimum number of animals necessary to produce reliable scientific data, and experiments were designed to minimize any animal distress.
Study Design
All rats were randomly divided into three experimental groups (15 rats per group). Each rat underwent behavorial testing via an open-field prior to implantation. For the sham stimulation group, animals were sedated and underwent surgery with implantation of the electrode with no stimulation. For the intermittent group, animals were administered stimulation for the same 3hrs/day for two weeks (14 days). The stimulation was turned on daily from 8am until 11am each day of the 14 day period. For the chronic group, animals were administered constant stimulation for two weeks (14 days). Chronic stimulation occurred 24 hours per day for the full 14 days. They underwent behavioral evaluation post stimulation period, and were then exposed to isoflurane and euthanized by decapitation. Brains were removed and used for protein extraction and analysis.
DBS Implantation
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Each rat underwent stereotactic placement of a 0.25mm bipolar stimulating electrode (Plastics One Products) on the right side. Rats were initially anesthetized with a combination of ketamine hydrochloride (100 mg/kg) and xylazine (2mg/kg) in saline and placed in a stereotaxic apparatus for surgery. Anesthesia was supplemented with isoflurane (Abbott Laboratories; 0.5-1.0%, in air) via a specialized nose cone affixed to the sterotaxic frame (Stoelting Corp.). The electrodes were placed via the coordinates determined by the Paxinos and Watson rat brain atlas (1.5mm anterior from bregma, 0.8mm medial/lateral, -7.4mm ventral from the top of the skull).
The electrode was secured using dental cement and the incision was closed using staples.
Each rat was allowed a 7-day recovery period after implantation. After this period they underwent stimulation via a continuous stimulus generator (Medtronic Screener Model 3638).
The stimulation parameters were frequency 120Hz, pulse width 200msec, and strength 2 volts.
The rats in the control group were connected to the generators which were not turned on.
Open field test
The open field was a square arena consisting of plexiglass walls and floor, measuring 
Brain Harvesting
The PFC extends from the rostrocaudal segment of the cerebral cortex and is located at a level 5.2 mm anterior to bregma and extends 3.3 posterior to bregma 30 . Anatomically forming the anterior part of the forebrain, the PFC is bounded medially by the median plane dividing the cerebral lobes, ventrally by the medial orbital cortex (5.2 mm anterior to bregma -3.2 mm anterior to bregma), dorsal peduncular cortex (3.2 mm anterior to bregma -2.2 mm anterior to bregma) or corpus callosum (1.7 mm anterior to bregma -3.3 mm posterior from bregma) and caudally by the occipital area 30 . In the present study, the PFC was microdissected (approximately covering the PFC area at a level 3.7 mm anterior to bregma extending at a level 1.7 posterior to bregma).
Protein extraction
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Brain tissue was rapidly removed from each animal and put on ice following the final behavioral analysis. Using a trephine, the prefrontal brain region was microdissected from each animal. The PFC was homogenized with a pestle and extracted in radioimmunoprecipitation assay lysis buffer (Santa Cruz Biotechnology) on ice for 20 min. Lysates were cleared by centrifugation at 13,000 rpm for 12 min at 41°C. Supernatants or protein extracts were diluted with an equal volume of Novex 2 ® tris glycine sodium dodecyl sulfate sample buffer (Invitrogen)
containing dithiothreitol (Sigma-Aldrich Inc.). Protein concentrations of the undiluted supernatants were quantified using the bicinchoninic acid protein assay reagent (Pierce, Rockford, IL).
Western blot analysis
Cell lysates containing equal amounts of protein were separated on 4-12% tris-glycine loading. The density of each band was quantified using Un-Scan-It blot analysis software (Silk Scientific Inc.). TH was normalized to β-actin immunoreactivity on each respective blot.
High Pressure Liquid Chromatography
Following the final behavioral analysis, PFC was sonicated in 1 ml of 0.1 M perchloric acid. A 100 µl aliquot of the sonicated material was stored at 80°C for protein determination using Pierce BCATM Protein Assay Kit (Thermo Scientific). The supernate was collected from centrifugation of the sonicated material at 13,000 g for15 min and stored at 70 °C until catecholamine extraction was performed. Catecholamines were extracted by alumina extraction from 100 µl of the sonicated supernate as previously described 31 . The eluted catechols were filtered through 0.22 Millex®GV syringe driven filter and detection was performed with the ESACoulochem II electrochemical detector (conditioning cell set at_350 mV, electrode 1 of analytical cell set at 90 mV, electrode2 of analytical cell set at _300 mV) (ESA). Phenomonex reverse phase c18 Gemini column (150_4.6 mm, 3_C, 110 A) (Phenomonex) and ScientificSoftware Inc. were used for data collection and analysis. The catecholamines, norepinephrine and dopamine were measured in the PFC. Catecholamine values were expressed as ng catecholamine/mg protein. Data were adjusted to percent control, and values were expressed as the average percent change from control ± SEM. Experimental data were analyzed by using the computer program GraphPad Prism (v. 5.0, GraphPad Software Inc.).
Golgi impregnation and morphological analysis
The brains were prepared using the FD Rapid Golgi Stain kit (FD Technologies (FD Neurotechnologies). Brains were placed in 20 ml Golgi-Cox solution (potassium dichromate, mercuric chloride and potassium chromate), where they were stored in the dark for 14 days.
After this incubation, sections containing PFC were obtained using a freezing microtome (100 10 µm; Micron HM550 cryostat; Richard-Allan Scientific) mounted onto gelatinized slides and coverslipped. Individual neurons and their processes were visualized at x100 using camera lucida. Dendritic length was measured in triplicate using National Institutes of Health Image J (National Institutes of Health).
Data Analysis
Statistical analyses were performed using Graph Pad In Stat software (Graph Pad Software Inc. (Table 1) . Wistar-Kyoto rats that received DBS of the NAcc showed significant increases (P < 0.05) in exploratory behavior and crossing of midline indicative of a reduction in depression and anxiety-like behavior.
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When comparing the three treatment groups to each other, baseline behavior during preimplantation showed no significant difference across the treatments. Post-implantation data showed a significant difference across all groups (P < 0.01) with the largest difference seen when comparing either the intermittent or chronic stimulation group to the control group. Control rats continued to exhibit depression-like and anxiety-like behaviors compared to either the intermittent or chronic stimulated groups (P < 0.01). There was a significant decrease (P < 0.01) in quadrant changes, as well as less time spent on hind legs (P < 0.001). In addition, the shamstimulated control group demonstrated almost no tendency to cross the midline and there was a significant decline (P < 0.001) in exploratory behavior and an increase in anxiety. Intermittent and chronic stimulation groups showed a significant increase (P < 0.01) in quadrant changes and time spent on hind legs, demonstrating increased exploratory behavior when compared to preimplantation and sham-stimulated controls. There was also a significant increase (P < 0.001) in crossing midline indicating less anxiety. There was a larger change observed in the chronic stimulation group than with the intermittent stimulation group when comparing to all pre-implant
values. These data demonstrate that there was a more significant behavioral response to treatment with chronic stimulation as opposed to intermittent stimulation.
DBS alters levels TH expression in the prefrontal cortex
In the present study, the PFC was microdissected (approximately covering the PFC area at a level 3.7 mm anterior to bregma extending at a level 1.7 posterior to bregma). Tyrosine hydroxylase protein expression following DBS was assessed using Western blot analysis.
Prefrontal cortex extracts from rats (n = 4 rats per group) that were euthanized following chronic stimulation group showed a significant decrease (P < 0.05) in TH expression levels compared to intermittent stimulation group and sham-stimulated control (Figur e 2). There was also a 
DBS alters levels NE and DA expression in the prefrontal cortex
DA and NE content in the PFC following chronic stimulation were assessed using HPLC.
DA and NE were chosen for testing secondary to being downstream in the biosynthetic pathway for catecholamine's and should be directly correlated with the effects observed with TH ( Figure   3 ). This aimed to determine if the decrease levels of the converting enzyme TH following chronic stimulation observed on Western blot analysis ( Figure 2 ) correlated with a decrease in the production of its neurotransmitters in the biosynthetic pathway for catecholamines. Statistical analysis showed that PFC extracts from rats (n = 4-5 rats per group) that were euthanized following chronic stimulation demonstrated a significant decrease in the content of NE (P < 0.05) and DA (P < 0.05) compared with sham-stimulated control (Figure 4 ).
DBS increases dendritic length in layer V pyramidal cells in the prefrontal cortex
Statistical analysis showed that intermittent and chronic stimulation for 14 days in the NAcc significantly increased apical (P < 0.01) and basilar (P < 0.01) dendritic length in the layer V pyramidal cells in the PFC ( Figure 5 ). However, there was no significant difference observed in the number of basilar dendritic branches in the three groups studied. Apical dendritic length did not significantly differ between intermittent stimulation group and chronic stimulation group. 
Methodological considerations
There are inherent caveats that exist with respect to Western blot analysis experiments. We specifically demonstrated in an open-field test that while sham-stimulated control rats continued to manifest signs of depression and anxiety, rats that received either intermittent or chronic DBS showed a significant reduction of depression and anxiety-like behaviors as evidenced by quadrant changes, time spent on hind legs, midline crossing, exploratory behavior and reduced anxiety when compared to pre-implantation and controls. There was a more significant behavioral response to treatment with chronic stimulation as opposed to intermittent stimulation. Control rats continued to be more depressed with age. The open field test is usually used to measure locomotor behavior and although useful in our experiment its interpretation of the behavior change is somewhat limited secondary to correlating behavioral change with depression and anxiety. That being said, the true significance of the behavioral data lies in that the control group worsened in all areas tested for behavioral analysis while the stimulation groups improved. This demonstrates that DBS of the NAcc did not only halt the progression of the disease process, but improved it, consistent with evidence showing that neuronal adaptation is disrupted in mood disorders and that treatments for depression would need to enhance neuroplasticity 40 . The present study also determines whether the behavioral changes following stimulation of the NAcc lead to changes in neural circuits, specifically the PFC.
It is anatomically established that NAcc receives afferent projections from PFC 41; 42; 43 .
The PFC is known for its vital role in a cognitive and behavioral processes including arousal, attention, cognition, motivation, working memory and vigilance 44 . The release of catecholamines, NE and dopamine, is related to arousal states that consequently have profound effects on cognitive and behavioral processes involving PFC functions 45; 46 . The PFC is very sensitive to changes to neurochemical environment so that any minute changes in catecholamine generate profound effects on the activity of PFC 47 . Indeed, the role of the medial PFC is important in understanding the NAcc and its circuitry therefore making it also important to understand the neuroadaptations in the PFC following DBS of NAcc.
Using Western blotting and HPLC, the levels of TH, norepinephrine (NE) and dopamine (DA), were determined, respectively, following DBS of the NAcc. Western blot analysis demonstrated a decrease in expression of TH in the PFC after both intermittent and chronic stimulation, although statistical significance was only observed in chronic stimulation. To determine if the decreased levels of the converting enzyme TH correlated with a decrease in the production of its neurotransmitters in the biosynthetic pathway for catecholamines, the levels of DA and NE were evaluated. The levels of DA and NE were significantly decreased in the PFC with chronic stimulation as compared to controls demonstrating a correlation with the decreased levels of TH. This was not observed in the intermittent stimulation group, as the levels of DA and NE mimicked that of the control group. This may be secondary to the less pronounced response in TH levels seen on the western blot analysis for intermittent stimulation. There may be a threshold in TH levels which needs to be breached before there are changes of levels in these neurotransmitters. It can also be hypothesized that this is why there was not as large a response in behavior changes in the intermittent stimulation group as compared to the chronic stimulation group.
DBS in the NAcc induces neuroplasticity in the prefrontal cortex.
The results of the present study showed that neurochemical alterations were evident on the expression levels of TH, DA and NE. Whether these neurochemical changes lead to morphological changes in neuronal structure, dendritic growth and branching were examined as markers for neuroplasticity. As a fundamental mechanism of neuronal adaptation, neuroplasticity is altered in stress paradigm in animals. Nevertheless, the present morphological data indicate that DBS of the NAcc influences dendritic plasticity in the PFC.
CONCLUSION
Our present results highlight DBS of the NAcc as a potential treatment modality for depression. In addition, our results present DBS of the NAcc as a mechanism that induces defined neurochemical changes and structural dendritic changes in the PFC that demonstrates neuroplasticity in the circuitry of the brain. It was shown that the effects of DBS may not only be 
